Tokyo, Japan

Etsuko Mitsuyama

This inventor holds 1 USPTO granted patent. Top assignee: Teijin Pharma Limited. Active years: 2015.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Etsuko Mitsuyama: Innovator in Pharmaceutical Chemistry

Introduction

Etsuko Mitsuyama is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential. Her work focuses on enhancing receptor activity, which is crucial for various medical applications.

Latest Patents

Etsuko Mitsuyama holds a patent for quaternary ammonium salt compounds. The objective of her invention is to provide a novel compound that exhibits β2 adrenergic receptor agonist activity and muscarinic receptor antagonist activity. The compounds she developed are represented by a specific formula and include pharmaceutically acceptable salts, showcasing superior activity in their respective roles.

Career Highlights

Throughout her career, Etsuko has been associated with Teijin Pharma Limited, where she has been instrumental in advancing research and development in pharmaceutical innovations. Her expertise in chemistry and pharmacology has led to breakthroughs that benefit the medical community.

Collaborations

Etsuko has collaborated with notable colleagues such as Satoshi Yamamura and Junji Igarashi. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Teijin Pharma Limited.

Conclusion

Etsuko Mitsuyama is a trailblazer in the field of pharmaceutical chemistry, with her innovative work paving the way for new therapeutic compounds. Her contributions are vital to the ongoing advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…